Peptide and glycopeptide dendrimers. Part II

Recent progress in peptide and glycopeptide chemistry make the preparation of peptide and glycopeptide dendrimers of acceptable purity, with designed structural and immunochemical properties reliable. New methodologies using unprotected peptide building blocks have been developed to further increase the possibilities of their design and improve their preparation and separation. The sophisticated design of peptide and glycopeptide dendrimers has led to their use as antigens and immunogens, for serodiagnosis and other biochemical uses including drug delivery. Dendrimers bearing peptide with predetermined secondary structures are useful tools in protein de novo design. This article covers synthesis and applications of multiple antigen peptides (MAPs), multiple antigen glycopeptides (MAGs), multiple antigen peptides based on sequential oligopeptide carriers (MAP‐SOCs), glycodendrimers and template‐assembled synthetic proteins (TASPs). In part II the preparation of MAPs, and the utility of glycodendrimers and TASPs are discussed. Copyright © 1999 European Peptide Society and John Wiley & Sons, Ltd.

[1]  R. Roy,et al.  Synthesis of Esterase-resistant 9-O-Acetylated Polysialoside as Inhibitor of Influenza C Virus Hemagglutinin , 1992 .

[2]  M. Ghadiri,et al.  A convergent approach to protein design. Metal ion-assisted spontaneous self-assembly of a polypeptide into a triple-helix bundle protein , 1992 .

[3]  M. Taylor,et al.  Biology of animal lectins. , 1993, Annual review of cell biology.

[4]  W. Hol,et al.  Structure determination of Panulirus interruptus haemocyanin at 3.2 A resolution. Successful phase extension by sixfold density averaging. , 1986, Journal of molecular biology.

[5]  T. Lindhorst,et al.  Glycocoating of Oligovalent Amines: Synthesis of Thiourea‐Bridged Cluster Glycosides from Glycosyl Isothiocyanates , 1996 .

[6]  Raymond A. Dwek,et al.  Glycobiology: Toward Understanding the Function of Sugars. , 1996, Chemical reviews.

[7]  M. Meldal.  4 – Glycopeptide Synthesis , 1994 .

[8]  N. Ahlborg,et al.  Generation of antibodies to human IL-12 and amphiregulin by immunization of Balb/c mice with diepitope multiple antigen peptides. , 1997, Journal of immunological methods.

[9]  J. Tam,et al.  Orthogonal coupling of unprotected peptide segments through histidyl amino terminus , 1997 .

[10]  B. Nardelli,et al.  Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses. , 1994, Vaccine.

[11]  B. Nardelli,et al.  Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine. , 1994, Molecular immunology.

[12]  S. Hoffman,et al.  Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. , 1995, Journal of immunology.

[13]  S. Muller,et al.  Synthetic peptides as antigens: pitfalls of conjugation methods. , 1985, Journal of immunological methods.

[14]  J. Tam,et al.  A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain. , 1988, The Journal of biological chemistry.

[15]  D. Valmori,et al.  Lack of H‐2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide , 1991, European journal of immunology.

[16]  William A. Goddard,et al.  Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter , 1990 .

[17]  M. Schubert.  COMPOUNDS OF THIOL ACIDS WITH ALDEHYDES , 1936 .

[18]  W. Bessler,et al.  Studies on the mitogenic principle of the lipoprotein from the outer membrane of Escherichia coli. , 1977, Biochemical and biophysical research communications.

[19]  K. Augustyns,et al.  Investigation on the stability of the Dde protecting group used in peptide synthesis: migration to an unprotected lysine. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[20]  Virander S. Chauhan,et al.  "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. , 1992, Journal of immunology.

[21]  S. Muller,et al.  Multiple autoepitope presentation for specific detection of antibodies in primary biliary cirrhosis , 1992, Hepatology.

[22]  J. Freund,et al.  ASPERMATOGENESIS, ANAPHYLAXIS, AND CUTANEOUS SENSITIZATION INDUCED IN THE GUINEA PIG BY HOMOLOGOUS TESTICULAR EXTRACT , 1955, The Journal of experimental medicine.

[23]  E. Jacotot,et al.  Pseudopeptide TASP Inhibitors of HIV Entry Bind Specifically to a 95-kDa Cell Surface Protein* , 1997, The Journal of Biological Chemistry.

[24]  B. Chait,et al.  Structural and functional properties of region II-plus of the malaria circumsporozoite protein , 1994, The Journal of experimental medicine.

[25]  N. Sharon,et al.  Protein glycosylation. Structural and functional aspects. , 1993, European journal of biochemistry.

[26]  K. Rose,et al.  Construction of protein analogues by site-specific condensation of unprotected fragments. , 1992, Bioconjugate chemistry.

[27]  Jean-Marie Lehn,et al.  Perspectives in Supramolecular Chemistry—From Molecular Recognition towards Molecular Information Processing and Self‐Organization , 1990 .

[28]  J. Bidart,et al.  Structural probing of human lutropin using antibodies raised against synthetic peptides constructed by classical and multiple antigen peptide system approaches. , 1990, Molecular immunology.

[29]  D. Wyss,et al.  Template-Assembled Synthetic Proteins with 4-Helix-Bundle Topology - Total Chemical Synthesis and Conformational Studies , 1992 .

[30]  F. Guibé,et al.  New allyl group acceptors for palladium catalyzed removal of allylic protections and transacylation of allyl carbamates , 1995 .

[31]  C. Leclerc,et al.  Synthetic immunomodulators and synthetic vaccines. , 1986, Critical reviews in therapeutic drug carrier systems.

[32]  E. Constable,et al.  Metallomicellanols: incorporation of ruthenium(II)–2,2′: 6′,2″-terpyridine triads into cascade polymers , 1993 .

[33]  R. Koganty,et al.  A novel glycosyl donor for the synthesis of cancer specific core 5 and sialyl core 5 as glycopeptide building blocks , 1997 .

[34]  C. Hawker,et al.  Unimolecular micelles and globular amphiphiles: dendritic macromolecules as novel recyclable solubilization agents , 1993 .

[35]  Marya Lieberman,et al.  IRON(II) ORGANIZES A SYNTHETIC PEPTIDE INTO THREE-HELIX BUNDLES , 1991 .

[36]  M. Taubman,et al.  Immunogenicity and protective immunity induced by synthetic peptides associated with a catalytic subdomain of mutans group streptococcal glucosyltransferase , 1997, Infection and immunity.

[37]  M. Ghadiri,et al.  Design of an artificial four-helix bundle metalloprotein via a novel ruthenium(II)-assisted self-assembly process , 1992 .

[38]  P. Perlmann,et al.  Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332 , 1996, Immunology.

[39]  Steven C. Zimmerman,et al.  Dendrimers in Supramolecular Chemistry: From Molecular Recognition to Self-Assembly. , 1997, Chemical reviews.

[40]  H. Rammensee,et al.  In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine , 1989, Nature.

[41]  J. Tam,et al.  Multiple antigen peptide. A novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays. , 1989, Journal of immunological methods.

[42]  C B Anfinsen,et al.  Antibodies reactive with native lysozyme elicited by a completely synthetic antigen. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Stephen Stinson.  DELVING INTO DENDRIMERS , 1997 .

[44]  K. Wooley.  From Dendrimers to Knedel‐like Structures , 1997 .

[45]  C. Leclerc,et al.  Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. A possible approach to a synthetic carbohydrate vaccine. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[46]  J. Tam,et al.  Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum. , 1993, Journal of immunology.

[47]  D C Richardson,et al.  The de novo design of protein structures. , 1989, Trends in biochemical sciences.

[48]  M. Uhlén,et al.  Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum‐reactive antibodies which inhibit parasite growth but not cytoadherence , 1995, Parasite immunology.

[49]  R. Lerner,et al.  Antibodies that react with predetermined sites on proteins. , 1983, Science.

[50]  V. Nussenzweig,et al.  Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria , 1990, The Journal of experimental medicine.

[51]  J. Tam,et al.  Multiple antigenic peptide method for producing antipeptide site-specific antibodies. , 1989, Methods in enzymology.

[52]  G. Fields,et al.  Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.

[53]  R. Buller,et al.  Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells , 1987, Nature.

[54]  B. Seed,et al.  Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. , 1990, Science.

[55]  S. Pierce,et al.  Design and immunological properties of topographic immunogenic determinants of a protein antigen (LDH-C4) as vaccines. , 1992, The Journal of biological chemistry.

[56]  J. Tam,et al.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[57]  M. Mutter,et al.  SYNTHESIS OF A 4-HELIX BUNDLE-LIKE TEMPLATE-ASSEMBLED SYNTHETIC PROTEIN (TASP) BY CONDENSATION OF A PROTECTED PEPTIDE ON A CONFORMATIONALLY CONSTRAINED CYCLIC CARRIER , 1990 .

[58]  D. Kemp,et al.  Resolution of the histidine problem for thiol capture--synthesis of a 39-peptide , 1991 .

[59]  D. Herrington,et al.  EFFECT OF PRIMING WITH CARRIER ON RESPONSE TO CONJUGATE VACCINE , 1989, The Lancet.

[60]  R. Brunham,et al.  Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis. , 1993, Journal of Immunology.

[61]  G. McLean,et al.  Generation of anti-peptide and anti-protein sera. Effect of peptide presentation on immunogenicity. , 1991, Journal of immunological methods.

[62]  J. Montreuil.  Primary structure of glycoprotein glycans: basis for the molecular biology of glycoproteins. , 1980, Advances in carbohydrate chemistry and biochemistry.

[63]  G. Fassina,et al.  Protein a mimetic peptide ligand for affinity purification of antibodies , 1996, Journal of molecular recognition : JMR.

[64]  O. Dangles,et al.  Use of an allylic anchor group and of its palladium catalyzed hydrostannolytic cleavage in the solid phase synthesis of protected peptide fragments , 1989 .

[65]  E. Claassen,et al.  Peptide‐induced memory (IgG) response, cross‐reactive with native proteins, requires covalent linkage of a specific B cell epitope with a T cell epitope , 1993, European journal of immunology.

[66]  E. Lederer,et al.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. , 1974, Biochemical and biophysical research communications.

[67]  Kay Severin,et al.  A synthetic peptide ligase , 1997, Nature.

[68]  L. Gera,et al.  Synthesis and stability of 3-nitro-2-pyridinesulfenyl chloride (NpysCl). , 2009, International journal of peptide and protein research.

[69]  C. Partidos,et al.  Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization. , 1993, Molecular immunology.

[70]  S. Hakomori,et al.  Synthetic immunochemistry of glycohexapeptide analogues characteristic of oncofetal fibronectin. Solid-phase synthesis and antigenic activity. , 2009, International journal of peptide and protein research.

[71]  S. R. Chhabra,et al.  Solid phase applications of Dde and the analogue Nde: Synthesis of trypanothione disulphide , 1997 .

[72]  T. King,et al.  Preparation of protein conjugates via intermolecular hydrazone linkage. , 1986, Biochemistry.

[73]  Y. Li,et al.  Preparation of protein conjugates via intermolecular disulfide bond formation. , 1978, Biochemistry.

[74]  J. Tam,et al.  Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes. , 1992, Journal of immunology.

[75]  M. Ghadiri,et al.  Secondary structure nucleation in peptides. Transition metal ion stabilized .alpha.-helices , 1990 .

[76]  M. T. Miranda,et al.  Solid-phase peptide synthesis at elevated temperatures: a search for and optimized synthesis condition of unsulfated cholecystokinin-12. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[77]  D. Kemp.  Peptidomimetics and the template approach to nucleation of β-sheets and α-helices in peptides , 1990 .

[78]  D. Evans,et al.  Activation of nonspecific cytotoxic cells with a multiple antigenic peptide: specificity and requirements for receptor crosslinkage. , 1996, Cellular immunology.

[79]  Richard A. Lerner,et al.  Tapping the immunological repertoire to produce antibodies of predetermined specificity , 1982, Nature.

[80]  T. Yokoyama,et al.  Preparation and characterization of antibodies against mouse prion protein (PrP) peptides , 1995, Clinical and diagnostic laboratory immunology.

[81]  E. Scanlon,et al.  Pancarcinoma T and Tn epitopes: autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis. , 1990, Immunology series.

[82]  J. Stewart,et al.  Design and synthesis of a peptide having chymotrypsin-like esterase activity. , 1990, Science.

[83]  J. Tam,et al.  Chemically unambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system. , 1991, Molecular immunology.

[84]  M. Jaye,et al.  Activation of Cytosolic Phospholipase A by Basic Fibroblast Growth Factor via a p42 Mitogen-activated Protein Kinase-dependent Phosphorylation Pathway in Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[85]  G. Fassina,et al.  Affinity purification of polyclonal antibodies using immobilized multimeric peptides. , 1995, Journal of chromatography. B, Biomedical applications.

[86]  J. Tam,et al.  Self-assembly of cyclic peptides on a dendrimer: multiple cyclic antigen peptides. , 1996, Peptide research.

[87]  H. Kleinman,et al.  Multimeric forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide enhance the inhibition of tumor growth and metastasis. , 1993, Cancer research.

[88]  T. Feizi.  Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens , 1985, Nature.

[89]  B. Nardelli,et al.  Design of a complete synthetic peptide-based AIDS vaccine with a built-in adjuvant. , 1992, AIDS research and human retroviruses.

[90]  M. Hearn,et al.  Direct synthesis and characterisation of multi-dendritic peptides for use as immunogens. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[91]  M. Fukuda,et al.  Cell surface glycoconjugates as onco-differentiation markers in hematopoietic cells. , 1985, Biochimica et biophysica acta.

[92]  M. Mutter,et al.  Ein chemischer Weg zu neuen Proteinen – Templat‐assoziierte synthetische Proteine (TASP) , 1989 .

[93]  E. Lederer,et al.  Adjuvant activity of monomeric bacterial cell wall peptidoglycans. , 1974, Biochemical and biophysical research communications.

[94]  W. Bessler,et al.  Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein. , 1983, Hoppe-Seyler´s Zeitschrift für physiologische Chemie.

[95]  J. Lasarte,et al.  Polarity of immunogens: implications for vaccine design , 1990, European journal of immunology.

[96]  A. Aletras,et al.  Preparation of the very acid-sensitive Fmoc-Lys(Mtt)-OH. Application in the synthesis of side-chain to side-chain cyclic peptides and oligolysine cores suitable for the solid-phase assembly of MAPs and TASPs. , 2009, International journal of peptide and protein research.

[97]  B. Matthews,et al.  Structure of thermolysin refined at 1.6 A resolution. , 1982, Journal of molecular biology.

[98]  C. Partidos,et al.  The effect of orientation of epitopes on the immunogenicity of chimeric synthetic peptides representing measles virus protein sequences. , 1992, Molecular immunology.

[99]  R. DiMarchi,et al.  Protection of cattle against foot-and-mouth disease by a synthetic peptide. , 1986, Science.

[100]  J. Gariépy,et al.  Loligomers: design of de novo peptide-based intracellular vehicles. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[101]  J. Harley,et al.  Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity , 1995, The Journal of experimental medicine.

[102]  N. Seidah,et al.  Application of the multiple antigenic peptides (MAP) strategy to the production of prophormone convertases antibodies: Synthesis, characterization and use of 8‐branched immunogenic peptides , 1995, Journal of peptide science : an official publication of the European Peptide Society.

[103]  Y. Kim,et al.  Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen. , 1992, Disease markers.

[104]  R. Cotran,et al.  Identification of an inducible endothelial-leukocyte adhesion molecule. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[105]  T. Lindhorst,et al.  Glycodendrimer synthesis without using protecting groups , 1997 .

[106]  J. Lehn.  Perspectives in supramolecular chemistry: From molecular recognition towards self-organisation , 1994 .

[107]  J. Fantini,et al.  Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages , 1994 .

[108]  M. Mutter,et al.  Solution structure of regioselectively addressable functionalized templates: an NMR and restrained molecular dynamics investigation. , 1998, Biopolymers.

[109]  Manfred Mutter,et al.  A Chemical Approach to Protein Design—Template‐Assembled Synthetic Proteins (TASP) , 1989 .

[110]  D. Ho,et al.  Macromolecular assemblage in the design of a synthetic AIDS vaccine. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[111]  E. Kaiser,et al.  Helichrome: synthesis and enzymic activity of a designed hemeprotein , 1989 .

[112]  J. Neil,et al.  Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain. , 1995, Immunology.

[113]  M. Mutter,et al.  Template assembled synthetic proteins (TASP) as functional mimetics of proteins , 1996 .

[114]  H. Mihara,et al.  Peptide and protein synthesis by segment synthesis-condensation. , 1989, Science.

[115]  S. Hakomori,et al.  Synthetic vaccines : synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins , 1994 .

[116]  J. Kihlberg,et al.  Preparation of Tn and sialyl Tn building blocks used in Fmoc solid-phase synthesis of glycopeptide fragments from HIV gp120 , 1997 .

[117]  P. Simmonds,et al.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 , 1993, Journal of clinical microbiology.

[118]  Molecular dynamics conformational search of six cyclic peptides used in the template assembled synthetic protein approach for protein de novo design , 1992, Biopolymers.

[119]  J. Tam.  High-density multiple antigen-peptide system for preparation of antipeptide antibodies. , 1989, Methods in enzymology.

[120]  S. Hoffman,et al.  Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides. , 1997, Journal of immunology.

[121]  G. Walter,et al.  Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen , 1984, Journal of virology.

[122]  M. Gefter,et al.  Immunological activity of covalently linked T-cell epitopes , 1990, Nature.

[123]  S. Brew,et al.  An unusual heparin-binding peptide from the carboxy-terminal hep-2 region of fibronectin. , 1994, Archives of biochemistry and biophysics.

[124]  D. Jue,et al.  Monopalmitic acid-peptide conjugates induce cytotoxic T cell responses against malarial epitopes: importance of spacer amino acids. , 1995, Journal of immunological methods.

[125]  R. Walter,et al.  3-nitro-2-pyridinesulfenyl (Npys) group. A novel selective protecting group which can be activated for peptide bond formation. , 2009, International journal of peptide and protein research.

[126]  R. Kurth,et al.  The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides. , 1994, Journal of immunology.

[127]  T. Creighton.  Toward a better understanding of protein folding pathways. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[128]  R. Boshuizen,et al.  Synthetic peptide vaccines: palmitoylation of peptide antigens by a thioester bond increases immunogenicity. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[129]  R. B. Merrifield.  Solid phase peptide synthesis. I. the synthesis of a tetrapeptide , 1963 .

[130]  H. Paulsen.  Syntheses, Conformations and X-Ray Structure Analyses of the Saccharide Chains from the Core Regions of Glycoproteins , 1990 .

[131]  N. Fotouhi,et al.  Peptide synthesis by prior thiol capture. IV: Amide bond formation: the effect of a side-chain substituent on the rates of intramolecular O,N-acyl transfer , 1986 .

[132]  W. Zeng,et al.  Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. , 1998, Vaccine.

[133]  E. Giralt,et al.  Solid-phase synthesis of peptides using allylic anchoring groups 2. Palladium-catalysed cleavage of Fmoc-protected peptides☆☆☆ , 1994 .

[134]  V. Braun,et al.  The lipoprotein of the outer membrane of Escherichia coli: a B- lymphocyte mitogen , 1975, The Journal of experimental medicine.

[135]  L. Echegoyen,et al.  Routes to Dendritic Networks: Bis‐Dendrimers by Coupling of Cascade Macromolecules through Metal Centers , 1995 .

[136]  Klaus Gubernator,et al.  The construction of new proteins: V. A template‐assembled synthetic protein (TASP) containing both a 4‐helix bundle and β‐barrel‐like structure , 1989, Proteins.

[137]  H. Fujimoto,et al.  Chemoenzymatic synthesis of Galα1-3Gal, Galα1-3Galβ1-4GlcNAc and their PEG-conjugates. , 1997 .

[138]  N. Ahlborg.  Synthesis of a diepitope multiple antigen peptide containing sequences from two malaria antigens using Fmoc chemistry. , 1995, Journal of immunological methods.

[139]  R. Roy,et al.  Solid-phase synthesis of dendritic sialoside inhibitors of influenza A virus haemagglutinin , 1993 .

[140]  G. Fassina,et al.  Inhibition of interleukin-2/p55 receptor subunit interaction by complementary peptides. , 1995, Archives of biochemistry and biophysics.

[141]  J. Fréchet,et al.  Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy. , 1994, Science.

[142]  G. Springer.  Tn epitope (N-acetyl-D-galactosamine alpha-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. , 1989, Molecular immunology.

[143]  R. Roy,et al.  Synthesis of novel dendritic glycosides , 1995 .

[144]  J. Tam,et al.  Unprotected Peptides as Building Blocks for the Synthesis of Peptide Dendrimers with Oxime, Hydrazone, and Thiazolidine Linkages , 1995 .

[145]  M. Mutter,et al.  Confromational Studies on Peptides Containing Enantiometric α-Methyl α-Amino Acids. Part I. Differential conformational properties of (R)- and (S)-2-methylaspartic acid , 1992 .

[146]  B. Nardelli,et al.  A chemically defined synthetic vaccine model for HIV-1. , 1992, Journal of immunology.

[147]  John T. Groves,et al.  Tetraphilin : a four-helix proton channel built on a tetraphenylporphyrin framework , 1992 .

[148]  J. Lasarte,et al.  Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide , 1991, European journal of immunology.

[149]  J. Tam,et al.  Coupling Difficulty Associated with Interchain Clustering and Phase Transition in Solid Phase Peptide Synthesis , 1995 .

[150]  James P. Tam,et al.  Synthesis and Application of Unprotected Cyclic Peptides as Building Blocks for Peptide Dendrimers , 1997 .

[151]  D. Kemp,et al.  The amine capture strategy for peptide bond formation—an outline of progress , 1981 .

[152]  K. P. Madhusudanan,et al.  Self-assembling bis-dendritic peptides: design, synthesis and characterization of oxalyl-linked bis-glutamyl peptides [Glu(n)(CO2Me)n + 1-CO-]2; n = 1,3,7. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[153]  H. Díaz,et al.  A dibenzofuran-based amino acid designed to nucleate antiparallel .beta.-sheet structure: evidence for intramolecular hydrogen-bond formation , 1992 .

[154]  G. Shapiro,et al.  Mild and rapid azide- mediated, palladium catalyzed cleavage of allylester based protecting groups , 1994 .

[155]  G. Springer.  T and Tn, general carcinoma autoantigens. , 1984, Science.

[156]  W. Bessler,et al.  Synthesis of novel immunologically active tripalmitoyl-S-glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations. , 2009, International journal of peptide and protein research.

[157]  K. Geoghegan,et al.  Site-directed conjugation of nonpeptide groups to peptides and proteins via periodate oxidation of a 2-amino alcohol. Application to modification at N-terminal serine. , 1992, Bioconjugate chemistry.

[158]  S. Kajigaya,et al.  Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. , 1995, Virology.

[159]  A. Tzinia,et al.  Use of sequential oligopeptide carriers (SOCn) in the design of potent Leishmania gp63 immunogenic peptides. , 1996, Peptide research.

[160]  E. Nardin,et al.  T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. , 1993, Annual review of immunology.

[161]  J. Fantini,et al.  Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. , 1994, The Journal of biological chemistry.

[162]  G. Fassina,et al.  Peptide-based assay for the identification of endothelin-converting enzyme inhibitors. , 1993, Peptide research.

[163]  G. Klein,et al.  Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. , 1994, Journal of autoimmunity.

[164]  R. B. Merrifield,et al.  Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. , 1981, Analytical biochemistry.

[165]  A. Capron,et al.  Analysis of antigenicity and immunogenicity of five different chemically defined constructs of a peptide. , 1992, Molecular immunology.

[166]  G. Look,et al.  Enzyme-catalyzed oligosaccharide synthesis. , 1992, Analytical biochemistry.

[167]  V. Tsikaris,et al.  Concept and design of a new class of sequential oligopeptide carriers (SOC) for covalent attachment of multiple antigenic peptides. , 1998, Biopolymers.

[168]  M. Madej,et al.  Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. , 1990, Cancer research.

[169]  H. Oettgen,et al.  GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. , 1995, Cancer research.

[170]  R. Roy,et al.  Novel Dendritic alpha-Sialosides: Synthesis of Glycodendrimers Based on a 3,3'-Iminobis(propylamine) Core. , 1996, The Journal of organic chemistry.

[171]  H. Kunz,et al.  Solid‐Phase Synthesis of a Tumor‐Associated Sialyl‐TN Antigen Glycopeptide with a Partial Sequence of the “Tandem Repeat” of the MUC‐1 Mucin , 1997 .

[172]  P. Alonso,et al.  Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia , 1993, The Lancet.

[173]  T. Toyokuni,et al.  Synthetic carbohydrate vaccines based on tumour-associated antigens , 1996 .

[174]  M. Mutter,et al.  Relationship between conformation and physicochemical properties of polypeptides. I. Synthesis of homo‐ and co‐oligopeptides by the liquid‐phase method , 1980 .

[175]  J. Schlom,et al.  Comparison of linear and branched peptide forms (MAPs) in the induction of T helper responses to point-mutated ras immunogens. , 1996, Cellular immunology.

[176]  R. Roy,et al.  Synthesis of New α-Thiosialodendrimers and Their Binding Properties to the Sialic Acid Specific Lectin from Limax flavus , 1997 .

[177]  W. Chan,et al.  A novel lysine-protecting procedure for continuous flow solid phase synthesis of branched peptides , 1993 .

[178]  B. Nardelli,et al.  Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide. , 1993, Immunology.

[179]  J. Tam,et al.  Peptide synthesis using unprotected peptides through orthogonal coupling methods. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[180]  J. Drijfhout,et al.  A new synthetic functionalized antigen carrier. , 2009, International journal of peptide and protein research.

[181]  P. Karachunski,et al.  Preferential pairing of T and B cells for production of antibodies without covalent association of T and B epitopes , 1994, European journal of immunology.

[182]  J. Kihlberg,et al.  Solid‐Phase Synthesis of Glycopeptides: Immunological Studies with T Cell Stimulating Glycopeptides , 1997 .

[183]  D. Gage,et al.  Dependence of the murine antibody response to an anti-CDR2 VH peptide on immunogen formulation. , 1995, Molecular immunology.

[184]  D. Bundle,et al.  Carbohydrate-protein interactions in antibodies and lectins , 1992, Current Biology.

[185]  G. McLean,et al.  Advantages of branched peptides in serodiagnosis. Detection of HIV-specific antibodies and the use of glycine spacers to increase sensitivity. , 1992, Journal of immunological methods.

[186]  S. Bombardieri,et al.  Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA. , 1995, Journal of immunological methods.

[187]  E. Constable.  Helices, Supramolecular Chemistry, and Metal‐directed Self‐Assembly , 1991 .

[188]  W. Bessler,et al.  Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten. , 1989, Biological chemistry Hoppe-Seyler.

[189]  D. Long,et al.  Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody , 1984, Journal of virology.

[190]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[191]  V. Ivanov,et al.  Synthetic peptides in the determination of hepatitis A virus T‐cell epitopes , 1994, FEBS letters.

[192]  B. W. Erickson,et al.  3 – Solid-Phase Peptide Synthesis , 1976 .

[193]  M. Fridkin,et al.  Thiolysis of the 3-nitro-2-pyridinesulfenyl (Npys) protecting group. An approach towards a general deprotection scheme in peptide synthesis. , 1990, International journal of peptide and protein research.

[194]  A. Otaka,et al.  Lymphocytes and promonocytes attach to the synthetic [Tyr5,12, Lys7]- polyphemusin II peptide. , 1994, Biochemical and biophysical research communications.

[195]  M. Sela,et al.  Effect of carrier on the immunogenic capacity of synthetic cholera vaccine. , 1985, Molecular immunology.

[196]  J. Clamp,et al.  THE PERIODATE OXIDATION OF AMINO ACIDS WITH REFERENCE TO STUDIES ON GLYCOPROTEINS. , 1965, The Biochemical journal.

[197]  H. X. Zhang,et al.  Allyl-based groups for side-chain protection of amino-acids. , 2009, International journal of peptide and protein research.

[198]  P. Dawson,et al.  Convenient total synthesis of a 4-helix template-assembled synthetic protein (TASP) molecule by chemoselective ligation , 1993 .

[199]  J. Tam,et al.  Unprotected peptides as building blocks for branched peptides and peptide dendrimers. , 2009, International journal of peptide and protein research.

[200]  Wilbur Ds.  Radiohalogenation of proteins: An overview of radionuclides, labeling methods and reagents for conjugate labeling , 1992 .

[201]  S. Muller,et al.  Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies. , 1992, Journal of immunological methods.

[202]  K. Rose,et al.  A synthetic peptide-based polyoxime vaccine construct of high purity and activity. , 1995, Molecular immunology.

[203]  S. Kent,et al.  Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein--the hepatitis B surface antigen. , 1982, Developments in biological standardization.

[204]  Herbert Benz,et al.  The Role of Solid-Phase Fragment Condensation (SPFC) in Peptide Synthesis , 2010 .

[205]  A. Satterthwait,et al.  The synthesis of peptide secondary structure mimetics with covalent hydrogen bond mimics on the solid support , 1994 .

[206]  I. Hamachi,et al.  Synthesis, metal-binding properties and polypeptide solubilization of ‘crowned’ arborols , 1994 .

[207]  J. Blake.  Peptide segment coupling in aqueous medium: silver ion activation of the thiolcarboxyl group. , 2009, International journal of peptide and protein research.

[208]  U. Birsner,et al.  Immunization and affinity purification of antibodies using resin-immobilized lysine-branched synthetic peptides. , 1994, Peptide research.

[209]  W. Hancock,et al.  A new micro-test for the detection of incomplete coupling reactions in solid-phase peptide synthesis using 2,4,6-trinitrobenzenesulphonic acid. , 1976, Analytical biochemistry.

[210]  K. Sperling,et al.  Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene , 1995, Molecular and cellular biology.

[211]  M. Jackwood,et al.  Production and immunogenicity of multiple antigenic peptide (MAP) constructs derived from the S1 glycoprotein of infectious bronchitis virus (IBV). , 1995, Advances in experimental medicine and biology.

[212]  K. Scheidtmann,et al.  Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[213]  E. Vatzaki,et al.  Construction and application of a new class of sequential oligopeptide carriers (SOCn) for multiple anchoring of antigenic peptides--application to the acetylcholine receptor (AChR) main immunogenic region. , 1996, International Journal of Biological Macromolecules.

[214]  T. Iwamoto,et al.  Use of the 3-nitro-2-pyridine sulfenyl protecting group to introduce N epsilon-branching at lysine during solid-phase peptide synthesis. I. Application to the synthesis of a peptide template containing two addressable sites. , 2009, International journal of peptide and protein research.

[215]  N. Fotouhi,et al.  Peptide synthesis by prior thiol capture. 6. Rates of the disulfide-bond-forming capture reaction and demonstration of the overall strategy by synthesis of the C-terminal 29-peptide sequence of BPTI , 1989 .

[216]  R. Feeney,et al.  Chemical modifications of proteins: history and applications. , 1990, Bioconjugate chemistry.

[217]  G. Ciliberto,et al.  A Multimeric Synthetic Peptide Combinatorial Library. , 1994, Peptide research.

[218]  S. Herrera,et al.  Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys , 1997, Parasite immunology.

[219]  S. Pierce,et al.  Peptides of 23 residues or greater are required to stimulate a high affinity class II‐restricted T cell response , 1993, European journal of immunology.

[220]  M. Mitchell,et al.  Synthetic immunogens constructed from T-cell and B-cell stimulating peptides (T:B chimeras): preferential stimulation of unique T- and B-cell specificities is influenced by immunogen configuration. , 1990, Cellular immunology.

[221]  I. Frazer,et al.  A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[222]  M. Mutter,et al.  Template‐Assembled Synthetic Proteins (TASP). Cyclic Templates with Incorporated Turn‐Inducing Mimics , 1993 .

[223]  W. Koff,et al.  Biodegradable microparticles with an entrapped branched octameric peptide as a controlled-release HIV-1 vaccine. , 1997, Journal of pharmaceutical sciences.

[224]  H. Kunz,et al.  Developments in the synthesis of glycopeptides containing glycosyl L-asparagine, L-serine, and L-threonine. , 1994, Advances in carbohydrate chemistry and biochemistry.

[225]  W. Bessler,et al.  Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B-, T-helper and T-killer cell response. , 2009, International journal of peptide and protein research.

[226]  G. Tuchscherer.  Template assembled synthetic proteins: Condensation of a multifunctional peptide to a topological template via chemoselective ligation , 1993 .

[227]  R. Koganty,et al.  Mucin type glycopeptides: Synthesis of Core 2, Core 6 and F1-α building blocks and some unexpected reactions , 1997 .

[228]  B. Nardelli,et al.  A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity. , 2009, International journal of peptide and protein research.

[229]  Virander S. Chauhan,et al.  Synthetic gonadotrophin-releasing hormone (GnRH) vaccines incorporating GnRH and synthetic T-helper epitopes. , 1993, Vaccine.

[230]  Christopher C. Moser,et al.  Design and synthesis of multi-haem proteins , 1994, Nature.

[231]  V. Braun,et al.  Covalent lipoprotein from the outer membrane of Escherichia coli. , 1975, Biochimica et biophysica acta.

[232]  J. Freund.  The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review. , 1951, American journal of clinical pathology.

[233]  B. Erlanger,et al.  Steroid-protein conjugates. I. Preparation and characterization of conjugates of bovine serum albumin with testosterone and with cortisone. , 1957, The Journal of biological chemistry.

[234]  B. Larsen,et al.  Photochemical conjugation of peptides to carrier proteins using 1,2,3-thiadiazole-4-carboxylic acid. Immunoreactivity of free C-terminal epitope with specific antibodies. , 2009, International journal of peptide and protein research.

[235]  H. Shimada,et al.  Antibody against synthetic multiple antigen peptides (MAP) of JC virus capsid protein (VP1) without cross reaction to BK virus: a diagnostic tool for progressive multifocal leukoencephalopathy , 1996, Neuroscience Letters.

[236]  Shui-Tein Chen,et al.  THE STUDIES OF MICROWAVE EFFECTS ON THE CHEMICAL REACTIONS , 1997 .

[237]  U. Natraj,et al.  Comparison of antibodies raised against the peptide 10-24 of chicken riboflavin carrier protein (cRCP) by classical and multiple antigen peptide (MAP) approaches. , 1996, Journal of immunological methods.

[238]  J. Fantini,et al.  SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[239]  J. Blanco,et al.  Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death. , 1996, Virology.

[240]  Yuan-chuan Lee,et al.  2 – Enhanced Biochemical Affinities of Multivalent Neoglycoconjugates , 1994 .

[241]  D. M. Grove,et al.  Homogeneous catalysts based on silane dendrimers functionalized with arylnickel(II) complexes , 1994, Nature.

[242]  P. Perlmann,et al.  Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: impact of epitope orientation. , 1998, Vaccine.

[243]  P. Leslie Dutton,et al.  Design of a heme-binding four-helix bundle , 1994 .

[244]  F. Vögtle,et al.  Dendrimers, Arborols, and Cascade Molecules: Breakthrough into Generations of New Materials , 1992 .

[245]  S. Hakomori,et al.  Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. , 1989, Advances in cancer research.

[246]  H. Kunz.  Synthesis of Glycopeptides, Partial Structures of Biological Recognition Components [New Synthetic Methods (67)] , 1987 .

[247]  M. Mutter,et al.  The Construction of New Proteins. Part III. Artificial folding units by assembly of amphiphilic secondary structures on a template , 1988 .

[248]  G. Fassina.  Oriented immobilization of peptide ligands on solid supports. , 1992, Journal of chromatography.

[249]  J. Tam,et al.  Assembly of cyclic peptide dendrimers from unprotected linear building blocks in aqueous solution , 1996 .

[250]  Christopher L. Brown,et al.  A CONVERGENT SYNTHESIS OF A CARBOHYDRATE-CONTAINING DENDRIMER , 1997 .

[251]  V. A. Bindra,et al.  Conformational preferences of oligopeptides rich in alpha-aminoisobutyric acid. III. Design, synthesis and hydrogen bonding in 3(10)-helices. , 2009, International journal of peptide and protein research.

[252]  T. Muir,et al.  Chemical ligation of unprotected peptides directly from a solid support. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[253]  F. Baleux,et al.  Novel version of Multiple Antigenic Peptide allowing incorporation on a cysteine functionalized lysine tree. , 2009, International journal of peptide and protein research.

[254]  J. Fantini,et al.  Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line , 1995, Journal of virology.

[255]  R. Roy,et al.  Macromolecular recognition: effect of multivalency in the inhibition of binding of yeast mannan to concanavalin A and pea lectins by mannosylated dendrimers. , 1996, Bioorganic & medicinal chemistry.

[256]  E. Baba,et al.  A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies. , 1995, Journal of immunology.

[257]  B. McGinn,et al.  Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants , 1987, Nature.

[258]  D. Tomalia,et al.  Genealogically directed synthesis: Starburst/cascade dendrimers and hyperbranched structures , 1993 .

[259]  R. Roy,et al.  Single step syntheses of lactosylated clusters by telomerizations , 1994 .

[260]  S. Hakomori,et al.  Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice. , 1991, Cancer research.

[261]  G. Schulz,et al.  Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. , 1982, The EMBO journal.

[262]  J. Tam.  12 – Synthesis and Applications of Branched Peptides in Immunological Methods and Vaccines , 1995 .

[263]  R E Oswald,et al.  A Topological Analysis of Goldfish Kainate Receptors Predicts Three Transmembrane Segments (*) , 1995, The Journal of Biological Chemistry.

[264]  J. Prieto,et al.  Simple strategy to induce antibodies of distinct specificity: Application to the mapping of gp120 and inhibition of HIV‐1 infectivity , 1995, European journal of immunology.

[265]  K. Rose.  Facile synthesis of homogeneous artificial proteins , 1994 .

[266]  P. Ho,et al.  Identification of two promiscuous T cell epitopes from tetanus toxin , 1990, European journal of immunology.

[267]  S. Hakomori,et al.  Possible functions of tumor-associated carbohydrate antigens. , 1991, Current opinion in immunology.

[268]  S. Benner,et al.  Synthesis, structure and activity of artificial, rationally designed catalytic polypeptides , 1993, Nature.

[269]  J. Tam,et al.  Cyclisation of totally unprotected peptides in aqueous solution by oxime formation , 1995 .

[270]  C. Leclerc,et al.  Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. , 1985, Journal of immunology.

[271]  F. Diederich,et al.  Dendrophanes: Water‐Soluble Dendritic Receptors. Preliminary communication , 1995 .

[272]  J. Hoflack,et al.  Characterization of anti-peptide antibodies directed towards the automodification domain and apoptotic fragment of poly (ADP-ribose) polymerase. , 1997, Biochimica et biophysica acta.

[273]  M. Mutter,et al.  A convenient synthesis of cyclic peptides as regioselectively addressable functionalized templates (RAFT) , 1995 .

[274]  M. Mutter,et al.  The TASP concept : Mimetics of peptide ligands, protein surfaces and folding units , 1993 .

[275]  F. Sinigaglia,et al.  Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein. , 1997, Journal of immunology.

[276]  R. L. Baldwin,et al.  How does protein folding get started? , 1989, Trends in biochemical sciences.

[277]  J. Neil,et al.  Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein. , 1996, Vaccine.

[278]  J. Tam,et al.  Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[279]  J. Tam,et al.  Peptide segment ligation strategy without use of protecting groups. , 1994, Proceedings of the National Academy of Sciences of the United States of America.